metoprolol has been researched along with oxprenolol in 109 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 68 (62.39) | 18.7374 |
| 1990's | 14 (12.84) | 18.2507 |
| 2000's | 17 (15.60) | 29.6817 |
| 2010's | 8 (7.34) | 24.3611 |
| 2020's | 2 (1.83) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; Gaillard, P; Schambel, P; Testa, B | 1 |
| Artursson, P; Beigi, F; Lundahl, P; Luthman, K; Palm, K; Strandlund, G; Ungell, AL | 1 |
| Ghuloum, AM; Jain, AN; Sage, CR | 1 |
| Danelian, E; Hämäläinen, MD; Hansson, A; Karlén, A; Karlsson, R; Lennernäs, H; Löfâs, S; Winiwarter, S | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Bleasby, K; Brown, CD; Dudley, AJ | 1 |
| Ertl, P; Rohde, B; Selzer, P | 1 |
| Artursson, P; Luthman, K; Norinder, U; Stenberg, P | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Caron, G; Ermondi, G | 1 |
| Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Carrupt, PA; Guillarme, D; Henchoz, Y; Rudaz, S; Veuthey, JL | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Bard, B; Carrupt, PA; Martel, S | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Antonsson, M; Bengtsson, O; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Jerndal, G; Wan, H; Winiwarter, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Akamatsu, M | 1 |
| Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Levy, JV | 1 |
| Meier, J | 1 |
| Erdmann, E; Krawietz, W; Pruchniewski, M; Weinsteiger, M | 1 |
| Kiechel, JR; Meier, J | 1 |
| Gioffrè, PA; Motolese, M; Nigri, A; Reale, A | 1 |
| Bellucci, R; Bonomi, L; Massa, F; Noya, E; Perfetti, S | 1 |
| Al-Zaibak, M; Anderson, EG; Calcraft, B; Jariwalla, AG | 1 |
| Tuomilehto, J | 1 |
| Nissinen, A; Tuomilehto, J | 1 |
| Clancy, A; Nicholson, AN; Wright, CM | 1 |
| Mutschler, E; Schäfer, M | 1 |
| Davidson, C; Singleton, W; Taylor, SH; Thadani, U | 2 |
| Dawes, CP; John, VA; Kendall, MJ | 1 |
| Ghani, P; Lopatin, IuM; Mareev, VIu; Sinitsin, VE | 1 |
| Allavena, A; Brambilla, G; Gazzaniga, GM; Martelli, A; Mazzei, M; Robbiano, L | 1 |
| Hughson, RL; Klein, CS; Kowalchuk, JM | 1 |
| Enquist, M; Hermansson, J | 1 |
| Fujiyama, K; Hoshino, T; Ikeda, T; Mashiba, H; Takeuchi, T; Tanaka, Y; Tominaga, M | 1 |
| Jonkers, R; Koopmans, RP; Oosterhuis, B; van Boxtel, CJ | 1 |
| Hughson, RL | 1 |
| Akritopoulos, P; Petounis, AD | 1 |
| Jackson, PR; Lewis, RV; Ramsay, LE | 2 |
| Kawecka-Jaszcz, K; Skoczeń, M | 1 |
| Cruickshank, JM; Neil-Dwyer, G | 1 |
| Hawksworth, GM; Petrie, JC; Rigby, JW; Scott, AK | 1 |
| Cybulska, I; Niegowska, J; Sznajderman, M; Zawadzki, Z | 1 |
| Fishbein, L; Jackson, CD | 1 |
| Halawa, B; Mazurek, W | 1 |
| Antonaccio, MJ; DeForrest, JM; High, J; Sybertz, E | 1 |
| Belpaire, FM; Bogaert, MG; Mugabo, P; Rosseel, MT | 1 |
| Dal Negro, RW; Pomari, C; Trevisan, F; Turco, P; Zoccatelli, O | 1 |
| Alexopoulos, D; Cobbe, SM; Manley, BS; Robinson, GJ | 1 |
| al-Gohary, O; Lyal, J; Murray, JB | 1 |
| Mutschler, E; Pflugmann, G; Spahn, H | 1 |
| Hirtz, J | 1 |
| John, VA; Moppert, J; Shotton, PA; Theobald, W | 1 |
| Ayer, A; Guittard, G; Khanna, S; Swanson, DR; Theeuwes, F | 1 |
| Fara, JW; Myrback, RE; Swanson, DR | 1 |
| Jutrin, I; Lang, R; Ravid, M | 1 |
| Asano, Y; Hosoda, S; Kusano, E; Takeda, K | 1 |
| Bloom, SR; Keen, H; Viberti, GC | 2 |
| Bishop, H; Kendall, MJ; Quarterman, CP; Schneider, RE | 1 |
| Hampton, JR; Wilcox, RG | 1 |
| Coltart, DJ; Hearse, DJ; Manning, AS; Yellon, DM | 1 |
| Lee, PS; Silke, B; Taylor, SH | 1 |
| Brotelle, R; Colot, M; de Clavière, M; Heyndrickx, JP | 1 |
| Lochan, R; Silke, B; Taylor, SH | 1 |
| Day, JL; Metcalfe, J; Simpson, CN | 1 |
| Alvares, RF; Goodwin, JF | 1 |
| Amery, A; Bulpitt, C; Cattaert, A; Fagard, R; Staessen, J; Vanhees, L | 1 |
| Hilal, A; Lee, PS; Silke, B; Taylor, SH | 1 |
| Hatori, Y; Horii, M; Nakamura, Y; Nemoto, E; Otsuka, K; Sakai, T; Tsukiyama, H; Yamamoto, Y; Yamato, T; Yoshii, Y | 1 |
| Auzépy, P; Boukara, N; Giudicelli, JF; Richard, C | 1 |
| Ostman, J | 1 |
| Weisswange, A | 1 |
| Sandström, B | 1 |
| Jack, DB; Kendall, MJ; Quarterman, CP; Smith, SR; Zaman, R | 1 |
| Chung, DC; Laschuk, MJ | 1 |
| Friedewald, WT; Frishman, WH; Furberg, CD | 1 |
| Dow, RJ; Fee, WM | 1 |
| Shanks, RG | 1 |
| Ferrara, LA; Mancini, M; Marotta, T; Mastranzo, P; Scilla, A; Strazzullo, P | 1 |
| Braakhekke, J; Folgering, H | 1 |
| Jenkins, RM; Nagle, RE | 1 |
| Leroux, F; Sandrenan, N; Sioufi, A | 1 |
| Besterman, EM; Comerford, MB | 1 |
| Caimi, G; Capobianco, D; Catania, A; Francavilla, G; Frazzetta, F; Sarno, A | 1 |
| Mehta, AC | 1 |
| Balasubramanian, V; Mann, S; Millar-Craig, MW; Raftery, EB | 1 |
| Badia, A; Vila, E | 1 |
| Hartonen, K; Riekkola, ML | 1 |
| Fraudeau, C; Luck, G; Mangani, F; Vérette, E | 1 |
| Caldwell, GW; Evangelisto, M; Masucci, JA; White, R | 1 |
| Caldwell, GW; Demarest, K; Easlick, SM; Gunnet, J; Masucci, JA | 1 |
| Hedeland, M; Isaksson, R; Jönsson, S; Pettersson, C | 1 |
| Banga, AK; Betageri, GV; Chaturvedula, A; Conjeevaram, R; Sunkara, G | 1 |
| D'Orazio, G; Fanali, S | 1 |
| Mizogami, M; Takakura, K; Tsuchiya, H | 1 |
| Jiang, X; Sun, N; Xi, Y; Zhang, Y | 1 |
| Esler, M; Grassi, G; Kjeldsen, SE; Kreutz, R; Mancia, G; Pathak, A | 1 |
| Chen, YW; Chou, AK | 1 |
10 review(s) available for metoprolol and oxprenolol
| Article | Year |
|---|---|
[Comparative pharmacokinetics of beta-blockers].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Timolol | 1978 |
[Beta-blockaders in the treatment of hypertension in pregnancy].
Topics: Adrenergic beta-Antagonists; Atenolol; Drug Evaluation; Female; Humans; Hypertension; Metoprolol; Oxprenolol; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol | 1985 |
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |
[Effect of beta-adrenolytic drugs on the survival of patients after myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Aftercare; Aged; Clinical Trials as Topic; Follow-Up Studies; Humans; Metoprolol; Middle Aged; Myocardial Infarction; Oxprenolol; Propranolol; Time Factors; Timolol | 1986 |
The gastrointestinal absorption of drugs in man: a review of current concepts and methods of investigation.
Topics: Body Water; Gastric Emptying; Humans; Intestinal Absorption; Kinetics; Metoprolol; Oxprenolol; Pharmaceutical Preparations | 1985 |
beta-adrenergic blockade and diabetes mellitus. A review.
Topics: Adrenergic beta-Antagonists; Alprenolol; Blood Glucose; Catecholamines; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Drug Synergism; Fatty Acids, Nonesterified; Gluconeogenesis; Glucose Tolerance Test; Glycerol; Glycogen; Humans; Hypertension; Hypoglycemia; Insulin; Lactates; Lactic Acid; Metoprolol; Oxprenolol; Propranolol | 1983 |
The new beta-adrenergic antagonists.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Labetalol; Metoprolol; Nadolol; Oxprenolol; Pindolol; Propanolamines; Timolol | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
Comparative efficacy of β-blockers on mortality and cardiovascular outcomes in patients with hypertension: a systematic review and network meta-analysis.
Topics: Adrenergic beta-Antagonists; Age Factors; Antihypertensive Agents; Atenolol; Coronary Disease; Humans; Hydrophobic and Hydrophilic Interactions; Hypertension; Incidence; Metoprolol; Network Meta-Analysis; Oxprenolol; Propranolol; Stroke; Treatment Outcome | 2017 |
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Comorbidity; Heart Failure; Humans; Hypertension; Metoprolol; Oxprenolol; Propranolol | 2022 |
26 trial(s) available for metoprolol and oxprenolol
| Article | Year |
|---|---|
Acute influence of different beta-blocking agents upon left heart hemodynamics at rest and during exercise in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Coronary Disease; Exercise Test; Female; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Oxprenolol; Propanolamines | 1979 |
A comparison between metroprolol, alprenolol and oxprenolol in the treatment of hypertension.
Topics: Alprenolol; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Follow-Up Studies; Humans; Hypertension; Metoprolol; Oxprenolol; Placebos; Propanolamines; Time Factors | 1979 |
Double-blind comparison of metoprolol, alprenolol, and oxprenolol in hypertension.
Topics: Adult; Aged; Alprenolol; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Oxprenolol; Propanolamines | 1979 |
Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
Topics: Adult; Angina Pectoris; Blood Pressure; Dose-Response Relationship, Drug; Drug Evaluation; Electrocardiography; Exercise Test; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Oxprenolol; Practolol; Propanolamines; Propranolol | 1979 |
Comparison of plasma and saliva levels of metoprolol and oxprenolol.
Topics: Adolescent; Adult; Amylases; Humans; Male; Metoprolol; Oxprenolol; Propanolamines; Saliva; Salivary Proteins and Peptides; Salivation; Time Factors | 1978 |
[Potential possibilities of using adrenergic beta blockers in chronic heart failure].
Topics: Adolescent; Adult; Aged; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Oxprenolol; Prognosis; Propranolol | 1992 |
A nonsteady-state agonist antagonist interaction model using plasma potassium concentrations to quantify the beta-2 selectivity of beta blockers.
Topics: Adrenergic beta-Antagonists; Adult; Female; Humans; Male; Metoprolol; Models, Biological; Oxprenolol; Potassium; Receptors, Adrenergic, beta; Terbutaline | 1989 |
Ramp work tests with three different beta-blockers in normal human subjects.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Heart Rate; Humans; Lactates; Male; Metoprolol; Oxprenolol; Oxygen Consumption; Physical Exertion; Propranolol | 1989 |
[Effect of beta-adrenolytic drugs on the survival of patients after myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Aftercare; Aged; Clinical Trials as Topic; Follow-Up Studies; Humans; Metoprolol; Middle Aged; Myocardial Infarction; Oxprenolol; Propranolol; Time Factors; Timolol | 1986 |
Respiratory effects of four adrenergic blocking agents combined with a diuretic in treating hypertension with concurrent chronic obstructive lung disease.
Topics: Adrenergic beta-Antagonists; Airway Resistance; Atenolol; Chlorthalidone; Drug Therapy, Combination; Forced Expiratory Volume; Humans; Hypertension; Labetalol; Lung Diseases, Obstructive; Male; Maximal Midexpiratory Flow Rate; Metoprolol; Oxprenolol; Random Allocation | 1986 |
The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
Topics: Adult; Aged; Analysis of Variance; Atenolol; Blood Pressure; Body Weight; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Oxprenolol; Physical Exertion; Propranolol; Prospective Studies; Pulse | 1985 |
Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Blood Pressure; Double-Blind Method; Exercise Test; Female; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Oxprenolol; Physical Exertion; Placebos; Practolol; Propanolamines; Propranolol; Time Factors | 1980 |
Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in normal subjects.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Diabetes Mellitus; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Hydrocortisone; Hypoglycemia; Insulin; Kinetics; Male; Metoprolol; Middle Aged; Oxprenolol; Propanolamines; Pulse | 1980 |
Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in insulin-dependent diabetics.
Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Blood Pressure; Diabetes Mellitus; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Hydrocortisone; Hypoglycemia; Insulin; Kinetics; Male; Metoprolol; Middle Aged; Oxprenolol; Propanolamines; Pulse | 1980 |
Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Female; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Oxprenolol; Physical Exertion; Random Allocation | 1981 |
Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Heart; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Metoprolol; Middle Aged; Oxprenolol; Practolol; Propranolol; Random Allocation; Sympathetic Nervous System; Vascular Resistance | 1982 |
Speed of onset of pharmacodynamic activity of propranolol, practolol, oxprenolol and metoprolol after intravenous infection in man.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Female; Heart Rate; Humans; Injections, Intravenous; Male; Metoprolol; Middle Aged; Oxprenolol; Practolol; Propranolol; Time Factors | 1981 |
Adrenergic mechanisms in control of plasma lipid concentrations.
Topics: Adrenergic beta-Antagonists; Atenolol; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Fatty Acids, Nonesterified; Female; Humans; Hypertension; Lipids; Lipoproteins, HDL; Lipoproteins, VLDL; Male; Metoprolol; Oxprenolol; Propranolol; Random Allocation; Triglycerides | 1982 |
Secondary prevention with beta-adrenoceptor blockers in post-myocardial infarction patients.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Metoprolol; Myocardial Infarction; Oxprenolol; Practolol; Propranolol; Recurrence; Sotalol; Timolol | 1982 |
[Improved prognosis using beta blockers after myocardial infarct?].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Oxprenolol; Prognosis; Propranolol; Sotalol; Timolol | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
Use of beta-blocking agents with group therapy in a smoking withdrawal clinic.
Topics: Adult; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Female; Humans; Male; Metoprolol; Middle Aged; Oxprenolol; Psychotherapy, Group; Smoking; Substance Withdrawal Syndrome | 1984 |
Effect of oxprenolol and metoprolol on serum lipid concentration.
Topics: Adult; Blood Pressure; Cholesterol; Female; Heart Rate; Humans; Lipids; Male; Metoprolol; Middle Aged; Oxprenolol; Triglycerides | 1984 |
The symptomatic and objective effects of nifedipine in combination with beta-blocker therapy in severe angina pectoris.
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Metoprolol; Middle Aged; Nifedipine; Nitroglycerin; Oxprenolol; Propanolamines; Pyridines | 1982 |
A comparison of the effects of the slow release formulations of metoprolol and oxprenolol in hypertension.
Topics: Adult; Delayed-Action Preparations; Female; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Oxprenolol; Propanolamines; Systole; Time Factors | 1982 |
Detection of beta-blockers in urine by solid-phase extraction-supercritical fluid extraction and gas chromatography-mass spectrometry.
Topics: Acetic Anhydrides; Acetylation; Adrenergic beta-Antagonists; Adult; Gas Chromatography-Mass Spectrometry; Humans; Hydrogen-Ion Concentration; Indicators and Reagents; Metoprolol; Oxprenolol; Propranolol; Pyridines | 1996 |
75 other study(ies) available for metoprolol and oxprenolol
| Article | Year |
|---|---|
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Topics: Indoles; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Propanolamines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1996 |
Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors.
Topics: Adrenergic beta-Antagonists; Amides; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Drug Design; Epithelial Cells; Formamides; Humans; Intestinal Absorption; Liposomes; Models, Molecular; Molecular Conformation; Monte Carlo Method; Permeability; Propanolamines; Structure-Activity Relationship | 1998 |
Molecular hashkeys: a novel method for molecular characterization and its application for predicting important pharmaceutical properties of molecules.
Topics: Drug Design; Intestinal Absorption; Models, Molecular; Pharmaceutical Preparations; Structure-Activity Relationship | 1999 |
SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans.
Topics: Humans; Intestinal Absorption; Liposomes; Pharmaceutical Preparations; Pharmacokinetics; Predictive Value of Tests; Surface Plasmon Resonance | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
The organic cation transporter OCT2 mediates the uptake of beta-adrenoceptor antagonists across the apical membrane of renal LLC-PK(1) cell monolayers.
Topics: Adrenergic beta-Antagonists; Biological Transport; Carrier Proteins; Cells, Cultured; Cimetidine; Hydrogen-Ion Concentration; Kidney; Metoprolol; Organic Cation Transport Proteins; Organic Cation Transporter 2; Propranolol; Quinolines | 2000 |
Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties.
Topics: Biological Availability; Biological Transport; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Reproducibility of Results | 2000 |
Experimental and computational screening models for the prediction of intestinal drug absorption.
Topics: Biological Transport; Carbon Radioisotopes; Cell Line; Cell Membrane; Cell Membrane Permeability; Ciprofloxacin; Computational Biology; Drug Design; Foscarnet; Humans; Hydrogen Bonding; Intestinal Absorption; Intestinal Mucosa; Lactulose; Mannitol; Models, Biological; Raffinose; Surface Properties; Tritium; Verapamil | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
High-throughput log P determination by ultraperformance liquid chromatography: a convenient tool for medicinal chemists.
Topics: Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Chromatography, Liquid; Mathematics; Pharmaceutical Preparations; Software | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.
Topics: Animals; Blood-Brain Barrier; Brain; Extracellular Fluid; Humans; Linear Models; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
Topics: Adrenergic beta-Antagonists; Aging; Alprenolol; Animals; Blood Pressure; Hypertension; Male; Metoprolol; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Pulse; Rats; Rats, Inbred Strains; Sodium Chloride; Sotalol; Stereoisomerism; Time Factors | 1976 |
Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents.
Topics: Adrenergic beta-Antagonists; Alprenolol; Biological Availability; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Protein Binding; Sotalol; Timolol | 1977 |
[Properties of beta-adrenergic receptors of heart and lung--studies with "cardioselective" beta-receptor blocking substances].
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Binding, Competitive; Heart; Lung; Metoprolol; Oxprenolol; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1977 |
Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Drug Tolerance; Ethanolamines; Intraocular Pressure; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Rabbits; Sotalol; Timolol | 1979 |
Persistent asthma after treatment with beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Aged; Asthma; Female; Humans; Male; Metoprolol; Middle Aged; Oxprenolol | 1979 |
Effect of metoprolol and oxprenolol on delayed differentiation behaviour in the monkey (Macaca mulatta) [proceedings].
Topics: Animals; Discrimination, Psychological; Haplorhini; Macaca mulatta; Male; Metoprolol; Oxprenolol; Propanolamines; Time Factors | 1977 |
Fluorimetric determination of oxprenolol in plasma by direct evaluation of thin-layer chromatograms.
Topics: Chromatography, Thin Layer; Fluorometry; Humans; Metoprolol; Oxprenolol | 1979 |
Formation of the N-nitroso derivatives of six beta-adrenergic-blocking agents and their genotoxic effects in rat and human hepatocytes.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Cell Survival; DNA; DNA Damage; DNA Repair; Humans; Liver; Male; Metoprolol; Nadolol; Nitrosamines; Nitrosation; Oxprenolol; Propranolol; Rats; Rats, Inbred Strains; Sodium Nitrite; Sotalol | 1991 |
The effect of beta-adrenergic blockade on leg blood flow with repeated maximal contractions of the triceps surae muscle group in man.
Topics: Adrenergic beta-Antagonists; Adult; Heart Rate; Humans; Leg; Male; Metoprolol; Muscle Contraction; Oxprenolol; Propranolol; Regional Blood Flow | 1990 |
Separation of the enantiomers of beta-receptor blocking agents and other cationic drugs using a CHIRAL-AGP column. Binding properties and characterization of immobilized alpha 1-acid glycoprotein.
Topics: Adrenergic beta-Antagonists; Adsorption; Alprenolol; Atenolol; Binding Sites; Butylamines; Chromatography; Metoprolol; Molecular Structure; Orosomucoid; Oxprenolol; Pindolol; Propranolol; Protein Conformation; Spectrometry, Fluorescence; Stereoisomerism | 1990 |
Acute effect of thyroid hormone on insulin secretion in rats.
Topics: Animals; Antithyroid Agents; Blood Glucose; Glucagon; In Vitro Techniques; Insulin; Male; Metoprolol; Oxprenolol; Pancreas; Rats; Rats, Inbred Strains; Thyroid Hormones | 1990 |
Influence of topical and systemic beta-blockers on tear production.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Butoxamine; Drug Administration Routes; Injections, Intramuscular; Lacrimal Apparatus; Male; Metoprolol; Oxprenolol; Propanolamines; Propranolol; Rabbits; Time Factors; Timolol | 1989 |
Side-effects of beta-adrenoceptor blocking drugs assessed by visual analogue scales.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Metoprolol; Oxprenolol; Propranolol; Surveys and Questionnaires | 1985 |
Beta-blocker brain concentrations in man.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Brain Chemistry; Cats; Humans; Lipid Metabolism; Metoprolol; Oxprenolol; Propranolol; Rats; Solubility; Species Specificity; Subarachnoid Hemorrhage; Tissue Distribution | 1985 |
Side-effects of beta-blockers assessed using visual analogue scales.
Topics: Acebutolol; Adrenergic beta-Antagonists; Analysis of Variance; Atenolol; Dreams; Fatigue; Humans; Hypertension; Metoprolol; Oxprenolol; Propranolol | 1985 |
A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Atenolol; Blood Proteins; Female; Half-Life; Humans; Hypertension; Kinetics; Male; Metoprolol; Oxprenolol; Propranolol; Protein Binding | 1985 |
[Effect of 3-month treatment with propranolol, oxprenolol, metoprolol and pindolol on plasma lipids and lipoproteins in patients with primary arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Female; Humans; Hypertension; Lipids; Male; Metoprolol; Middle Aged; Oxprenolol; Pindolol; Propranolol; Time Factors | 1985 |
Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
Topics: Acebutolol; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Blood Pressure; Decerebrate State; Heart; Heart Rate; Hypertension; Isoproterenol; Levobunolol; Male; Metoprolol; Oxprenolol; Propranolol; Rats; Rats, Inbred SHR; Renin; Sympathetic Nervous System; Sympathomimetics; Time Factors | 1986 |
Binding to serum alpha 1-acid glycoprotein and effect of beta-adrenoceptor antagonists in rats with inflammation.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Heart Rate; Inflammation; Injections, Intravenous; Male; Metoprolol; Orosomucoid; Oxprenolol; Portal Vein; Propranolol; Protein Binding; Rats; Rats, Inbred Strains | 1986 |
Subsidiary class III effects of beta blockers? A comparison of atenolol, metoprolol, nadolol, oxprenolol and sotalol.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Atenolol; Dose-Response Relationship, Drug; Isomerism; Metoprolol; Muscle Contraction; Nadolol; Oxprenolol; Papillary Muscles; Rabbits; Refractory Period, Electrophysiological; Sotalol | 1986 |
Adsorption of antihypertensives by suspensoids. Part 2. The adsorption of acebutolol, metoprolol, nadolol, oxprenolol, and timolol by attapulgite, charcoal, kaolin and magnesium trisilicate.
Topics: Acebutolol; Adsorption; Antihypertensive Agents; Charcoal; Kaolin; Magnesium; Magnesium Compounds; Magnesium Silicates; Metoprolol; Nadolol; Oxprenolol; Silicic Acid; Silicon; Silicon Compounds; Timolol | 1988 |
Rapid determination of the enantiomers of metoprolol, oxprenolol and propranolol in urine.
Topics: Biotransformation; Chromatography, Thin Layer; Humans; Indicators and Reagents; Metoprolol; Oxprenolol; Propranolol; Spectrometry, Fluorescence; Stereoisomerism | 1987 |
Gastrointestinal transit of Oros drug delivery systems in healthy volunteers: a short report.
Topics: Delayed-Action Preparations; Digestive System; Humans; Metoprolol; Oxprenolol | 1985 |
Oros drug delivery systems for the beta-adrenoreceptor antagonists oxprenolol and metoprolol.
Topics: Animals; Delayed-Action Preparations; Humans; Metoprolol; Oxprenolol | 1985 |
Osmotic delivery systems for the beta-adrenoceptor antagonists metoprolol and oxprenolol: design and evaluation of systems for once-daily administration.
Topics: Delayed-Action Preparations; Drug Compounding; Drug Stability; Humans; Hydrogen-Ion Concentration; Kinetics; Metoprolol; Models, Theoretical; Osmosis; Oxprenolol; Solubility | 1985 |
Evaluation of oxprenolol and metoprolol Oros systems in the dog: comparison of in vivo and in vitro drug release, and of drug absorption from duodenal and colonic infusion sites.
Topics: Animals; Colon; Delayed-Action Preparations; Dogs; Duodenum; Female; Intestinal Absorption; Kinetics; Male; Metoprolol; Oxprenolol | 1985 |
Beta-antagonist and secondary hyperparathyroidism in chronic renal failure.
Topics: Adult; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Metoprolol; Middle Aged; Oxprenolol | 1985 |
Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Proteins; Blood Sedimentation; Female; Humans; Inflammation; Liver; Male; Metoprolol; Middle Aged; Oxprenolol; Propranolol; Protein Binding | 1981 |
Abrupt withdrawal of chronic beta-blockade: adaptive changes in cyclic AMP and contractility.
Topics: Adaptation, Physiological; Adrenergic beta-Antagonists; Animals; Cyclic AMP; Heart; Heart Rate; Humans; Isoproterenol; Male; Metoprolol; Myocardial Contraction; Myocardium; Oxprenolol; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1981 |
Variability in the preventive action of the B-blockers on genetic hypertension in the rat.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Blood Pressure; Dose-Response Relationship, Drug; Hypertension; Male; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Rats; Rats, Inbred Strains; Species Specificity; Time Factors | 1980 |
Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Cardiomyopathy, Hypertrophic; Diastole; Female; Heart; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Oxprenolol; Propranolol | 1982 |
Haemodynamic dose-response effects of intravenous beta-blocking drugs with different ancillary properties in patients with coronary heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiac Output; Coronary Disease; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Metoprolol; Middle Aged; Oxprenolol; Practolol; Propranolol; Pulmonary Wedge Pressure | 1982 |
Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Carteolol; Hemodynamics; Humans; Hypertension; Metoprolol; Oxprenolol; Propranolol | 1983 |
[Acute poisoning caused by beta blockers in the adult. Apropos of 7 cases].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Alcohol Drinking; Bradycardia; Coma; Dose-Response Relationship, Drug; Female; Humans; Male; Metoprolol; Middle Aged; Oxprenolol; Propranolol; Seizures | 1983 |
Clinical trials of adrenergic antagonists in pregnancy hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Apgar Score; Birth Weight; Female; Fetal Growth Retardation; Humans; Hydralazine; Hypertension; Infant, Newborn; Methyldopa; Metoprolol; Oxprenolol; Pregnancy; Pregnancy Complications, Cardiovascular; Respiratory Distress Syndrome, Newborn | 1984 |
Beta-adrenoceptor blocker pharmacokinetics and the oral contraceptive pill.
Topics: Acebutolol; Adrenergic beta-Antagonists; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Drug Interactions; Female; Humans; Kinetics; Metoprolol; Oxprenolol; Propranolol; Time Factors | 1984 |
Studies with long acting propranolol.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Delayed-Action Preparations; Half-Life; Heart Rate; Humans; Hypertension; Metoprolol; Oxprenolol; Physical Exertion; Propranolol | 1984 |
Ventilatory response to hypercapnia in normal subjects after propranolol, metoprolol and oxprenolol.
Topics: Adult; Carbon Dioxide; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Hypercapnia; Male; Maximal Expiratory Flow Rate; Metoprolol; Oxprenolol; Propanolamines; Propranolol; Respiration | 1980 |
Gas chromatographic determination of metoprolol in human plasma.
Topics: Biological Availability; Chromatography, Gas; Humans; Metoprolol; Oxprenolol; Propanolamines | 1983 |
[Behavior of the hemorrheological pattern in subjects with essential hypertension treated with beta-blocking agents. II. Metoprolol and oxprenolol].
Topics: Adult; Blood Flow Velocity; Blood Viscosity; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Oxprenolol; Propanolamines | 1982 |
High-performance liquid chromatographic determination of oxprenolol hydrochloride and metoprolol tartrate in tablets and injections.
Topics: Chromatography, High Pressure Liquid; Injections; Metoprolol; Oxprenolol; Propanolamines; Solutions; Tablets | 1982 |
Effects of treatment on circadian rhythms of blood pressure.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Circadian Rhythm; Heart Rate; Humans; Hypertension; Labetalol; Metoprolol; Oxprenolol | 1981 |
Chronic administration of oxprenolol and metoprolol attenuate sympathetic cardiovascular responses only in non-adrenalectomized pithed rats.
Topics: Adrenalectomy; Adrenergic beta-Antagonists; Animals; Electric Stimulation; Epinephrine; Hemodynamics; Metoprolol; Norepinephrine; Oxprenolol; Rats; Rats, Sprague-Dawley | 1995 |
On-line column-switching high-performance liquid chromatography analysis of cardiovascular drugs in serum with automated sample clean-up and zone-cutting technique to perform chiral separation.
Topics: Cardiovascular Agents; Chromatography, High Pressure Liquid; Diltiazem; Lidocaine; Linear Models; Metoprolol; Online Systems; Oxprenolol; Pindolol; Sensitivity and Specificity; Stereoisomerism; Verapamil | 1997 |
Evaluation of the immobilized artificial membrane phosphatidylcholine. Drug discovery column for high-performance liquid chromatographic screening of drug-membrane interactions.
Topics: Acebutolol; Acetonitriles; Adrenergic beta-Antagonists; Alprenolol; Aniline Compounds; Atenolol; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Membranes, Artificial; Metoprolol; Models, Chemical; Osmolar Concentration; Oxprenolol; Phosphatidylcholines; Pindolol; Propranolol; Reproducibility of Results; Timolol | 1998 |
In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Atenolol; Biological Availability; Caco-2 Cells; Cell Membrane Permeability; Chromatography, Liquid; Epithelial Cells; Humans; Intestinal Absorption; Intestinal Mucosa; Mass Spectrometry; Metoprolol; Molecular Structure; Oxprenolol; Pindolol; Propranolol; Research Design; Timolol | 1998 |
Unexpected difference in enantioselective retention on cellulase (CHB I) silica stationary phase caused by exchange of potassium for sodium ion in the mobile phase.
Topics: Adrenergic beta-Antagonists; Buffers; Cellulase; Metoprolol; Oxprenolol; Potassium; Silicon Dioxide; Sodium; Spectrophotometry, Ultraviolet; Stereoisomerism; Temperature | 1998 |
Iontophoretic in vivo transdermal delivery of beta-blockers in hairless rats and reduced skin irritation by liposomal formulation.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Animals; Biological Transport; Chromatography, High Pressure Liquid; Drug Carriers; Injections, Intravenous; Iontophoresis; Irritants; Liposomes; Metoprolol; Oxprenolol; Propranolol; Rats; Skin; Skin Absorption; Sotalol; Stereoisomerism; Timolol | 2003 |
Enantiomeric separation by using nano-liquid chromatography with on-column focusing.
Topics: Adrenergic beta-Antagonists; Alprenolol; Calibration; Chromatography, Liquid; Metoprolol; Nanotechnology; Oxprenolol; Particle Size; Propranolol; Reproducibility of Results; Silicon Dioxide; Stereoisomerism; Time Factors; Vancomycin | 2008 |
The interactivities with lipid membranes differentially characterize selective and nonselective beta1-blockers.
Topics: Adrenergic beta-Antagonists; Alprenolol; Anesthesia; Anesthetics; Atenolol; Biomimetics; Lipid Bilayers; Lipids; Liposomes; Membranes, Artificial; Metoprolol; Oxprenolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 2010 |
Beta-blocker carteolol and oxprenolol produce cutaneous analgesia in response to needle pinpricks in the rat.
Topics: Acebutolol; Analgesia; Anesthetics, Local; Animals; Bupivacaine; Butoxamine; Carteolol; Dose-Response Relationship, Drug; Epinephrine; Metoprolol; Oxprenolol; Pain; Rats; Rats, Sprague-Dawley | 2023 |